Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 559

1.

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.

Wright PW, Li H, Huehn A, O'Connor GM, Cooley S, Miller JS, Anderson SK.

Genes Immun. 2014 Jul 3. doi: 10.1038/gene.2014.34. [Epub ahead of print]

PMID:
24989671
[PubMed - as supplied by publisher]
2.

Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.

Chen X, Liu H, Peng Y, He L, Zhang Y, Xie Y, Peng X, Liu C, Liu F.

Cell Immunol. 2014 May-Jun;289(1-2):70-5. doi: 10.1016/j.cellimm.2014.03.004. Epub 2014 Mar 30.

PMID:
24732061
[PubMed - indexed for MEDLINE]
3.

Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.

J Immunol. 2014 Mar 15;192(6):2875-84. doi: 10.4049/jimmunol.1303142. Epub 2014 Feb 21.

PMID:
24563253
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.

Blum S, Csurhes P, Reddel S, Spies J, McCombe P.

J Neuroimmunol. 2014 Feb 15;267(1-2):92-6. doi: 10.1016/j.jneuroim.2013.12.007. Epub 2013 Dec 12.

PMID:
24367901
[PubMed - indexed for MEDLINE]
5.

TNFR-associated factor 6 and TGF-β-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor.

Rajagopalan S, Lee EC, DuPrie ML, Long EO.

J Immunol. 2014 Jan 15;192(2):714-21. doi: 10.4049/jimmunol.1302384. Epub 2013 Dec 11.

PMID:
24337384
[PubMed - indexed for MEDLINE]
6.

Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.

Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS.

J Immunol. 2014 Jan 15;192(2):732-40. doi: 10.4049/jimmunol.1301748. Epub 2013 Dec 11.

PMID:
24337374
[PubMed - indexed for MEDLINE]
7.

KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission.

Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT.

Clin Immunol. 2013 Dec;149(3):498-508. doi: 10.1016/j.clim.2013.09.005. Epub 2013 Sep 25.

PMID:
24239756
[PubMed - indexed for MEDLINE]
8.

Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, Einarson MB, Zhou Y, Braiman A, Campbell KS, Porgador A.

J Immunol. 2013 Nov 15;191(10):5256-67. doi: 10.4049/jimmunol.1302079. Epub 2013 Oct 14.

PMID:
24127555
[PubMed - indexed for MEDLINE]
9.

Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.

Zhou J, Tang X, Ding Y, An Y, Zhao X.

Pediatr Allergy Immunol. 2013 Nov;24(7):691-6. doi: 10.1111/pai.12130.

PMID:
24112428
[PubMed - indexed for MEDLINE]
10.

KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.

Jiang Y, Chen O, Cui C, Zhao B, Han X, Zhang Z, Liu J, Xu J, Hu Q, Liao C, Shang H.

BMC Infect Dis. 2013 Sep 2;13:405. doi: 10.1186/1471-2334-13-405.

PMID:
24059286
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Bari R, Rujkijyanont P, Sullivan E, Kang G, Turner V, Gan K, Leung W.

J Clin Oncol. 2013 Oct 20;31(30):3782-90. doi: 10.1200/JCO.2012.47.4007. Epub 2013 Sep 16.

PMID:
24043749
[PubMed - indexed for MEDLINE]
12.

Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.

Grifoni A, Montesano C, Patronov A, Colizzi V, Amicosante M.

Biomed Res Int. 2013;2013:283805. doi: 10.1155/2013/283805. Epub 2013 Aug 1.

PMID:
23984333
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Qualitative analysis of accented CD158a receptor expression in NK-lymphocytes in women with reproductive failures].

Dons'koĭ BV, Chernyshov VP, Sudoma IO, Honcharova IaO, Osypchuk DV.

Lik Sprava. 2013 Jan-Feb;(1):86-93. Ukrainian.

PMID:
23951916
[PubMed - indexed for MEDLINE]
14.

NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome.

Schneider P, Plassa LF, Ratajczak P, Leboeuf C, Verneuil L, Battistella M, Bensussan A, Bagot M, Janin A.

J Invest Dermatol. 2014 Feb;134(2):574-8. doi: 10.1038/jid.2013.321. Epub 2013 Jul 30. No abstract available.

PMID:
23900021
[PubMed - indexed for MEDLINE]
15.

KIR2DL1-HLA signaling pathway: notable inhibition in the cytotoxicity of allo-NK cell against KG1A cell.

Xue TY, He YZ, Zhang JJ, Zhang XY, Xin YJ, Lu Y, Li YH.

Clin Lab. 2013;59(5-6):613-9.

PMID:
23865361
[PubMed - indexed for MEDLINE]
16.

High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections.

Ji HF, Wang J, Yu L, Niu JQ, Ayana DA, Jiang YF.

Ann Hepatol. 2013 Jul-Aug;12(4):539-47.

PMID:
23813131
[PubMed - indexed for MEDLINE]
17.

Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.

Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK.

J Immunol. 2013 Jun 15;190(12):6198-208. doi: 10.4049/jimmunol.1300464. Epub 2013 May 17.

PMID:
23686481
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.

Pembroke T, Christian A, Jones E, Hills RK, Wang EC, Gallimore AM, Godkin A.

Gut. 2014 Mar;63(3):515-24. doi: 10.1136/gutjnl-2013-304472. Epub 2013 May 11.

PMID:
23665989
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.

Shahid A, Chopera DR, Martin E, Penney KA, Milloy MJ, Brumme ZL.

J Immunol Methods. 2013 May 31;391(1-2):154-62. doi: 10.1016/j.jim.2013.03.005. Epub 2013 Mar 21.

PMID:
23524032
[PubMed - indexed for MEDLINE]
20.

Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity.

Varchetta S, Oliviero B, Mavilio D, Mondelli MU.

Cytokine. 2013 Apr;62(1):58-63. doi: 10.1016/j.cyto.2013.02.018. Epub 2013 Mar 13.

PMID:
23490421
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk